Re:Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: Analysis of STOMP and ORIOLE trials
机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, PR China.四川大学华西医院[2]Department of Urology, West China Hospital, West China Medical School, Sichuan University, 37 Guoxue Street, Chengdu, 610041, PR China.四川大学华西医院
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
推荐引用方式(GB/T 7714):
Cao Shangqi,Hu Xu,Shao Yanxiang,et al.Re:Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: Analysis of STOMP and ORIOLE trials[J].Asian journal of surgery.2022,doi:10.1016/j.asjsur.2022.11.099.
APA:
Cao Shangqi,Hu Xu,Shao Yanxiang&Li Xiang.(2022).Re:Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: Analysis of STOMP and ORIOLE trials.Asian journal of surgery,,
MLA:
Cao Shangqi,et al."Re:Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: Analysis of STOMP and ORIOLE trials".Asian journal of surgery .(2022)